Premenstrual Syndromes : PMS and PMDD - Rutuja :: The site ...

Index
Note to index: PMS is used for PMS/PMDD; italic page numbers denote illustrations/tables.
affective adaptation, actions of ovarian steroids 86–8
allopregnanolone
decreased 3alpha-HSD activity 176
and GABA A receptor 70, 176, 118
properties 162
structure and synthesis 71
androgenic steroids 112, 124
androgens 64, 66
etiology of PMS 109
androstenedione 64
antidepressants 131–7
continuous dosing 132, 135
intermittent dosing 133, 135
anxiety disorders 52
GABAA receptor alpha-4 subunit 71
anxiolytics 136, 137, 155
benzodiazepines 118
black cohosh Cimifuga racemosa 113
bone mineral density, monitoring 125
brain neurotransmitters see neurotransmitter physiology
breast cancer 123
calcium, diet supplements 145, 145, 153
catamenial episodes 13
chasteberry Vitex agnus-castus 113, 144
cholesterol, steroidogenesis, synthetic pathways 83–5, 84
Cimifuga racemosa (black cohosh) 113
clinical evaluation and management 149–59
clinical presentation of premenstrual symptoms 55–61
assessment tools 58
course of PMS 56–7
evidence of distinct disorder 56
mood symptoms 86–8, 117–20, 162, 172–3
and GABA system 71–2
premenstrual exacerbations 59
progesterone-induced mood symptoms 117–18, 162,
172–3
somatic symptoms 22, 24–5, 75, 161–6
symptom provocation 117
clinical trials 42–4
antidepressants 134–7
cognitive behavioral therapy (CBT) 153
combined oral contraceptives pills (COCPs) 121, 153–4
comorbidity of PMS 49–54
complementary/alternative (CAM) therapy 141–51, 156
definitions 141–3
modalities 142–3
motivation for 143
conception cycle 66–7
corpus luteum 65–6
hormone ‘replacement’ therapy 88
‘luteal phase abnormality’ 88
symptom provocation 117
Daily Record of Severity of Problems 28–9, 32, 152–3
Dalton, Katharina 3
danazol 112, 124, 156
ovarian cycle suppression 124
data collection 34–5
definitions of PMS/PMDD 49–50
depressive disorders 50–1, 161
bipolar disorder 51
major depressive disorder (MDD) 50–1
unipolar disorder 50–1
diagnosis of PMS 9–19
catamenial episodes 13
course of syndrome 56–7
criteria 12, 57–9, 149–53
ACOG 11, 57, 150
APA DSM-IV 11–12, 31–4, 150
ICD-10 10–11, 57